Overview Fundamentals API Earnings EOD API Sample Code Pricing

Telesis Bio Inc. (TBIO NASDAQ) stock market data APIs

$4.18 0.35(9.1%) as of September 6, 2024
Price chart is built with Anychart

Telesis Bio, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. The company offers BioXp 3250 system and BioXp 9600 system that empower researchers to go from a digital DNA sequence to endpoint-ready synthetic deoxyribonucleic acid (DNA) and messenger ribonucleic acid (mRNA) with onboard next generation sequencing (NGS) library preparation; BioXp portal, an online portal that offers an intuitive guided workflow and design tools for building new DNA sequences and assembling them into vectors of choice, as well as mRNA constructs; and BioXp De Novo kits, which contains building blocks and reagents, including proprietary Gibson assembly branded reagents for specific synthetic biology workflow applications. It also provides BioXp Select kits that offers to use non-telesis bio DNA while using the BioXp system to perform synthetic biology workflow applications, such as cloning, mRNA generation from plasmid, and cell free amplification; BioXp Next Generation Sequencing kits, which contains reagents to go from DNA or RNA to a sequencer-ready library; Benchtop reagents that contains the reagents to proceed specific synthetic biology workflow on the benchtop using products generated on the BioXp system; and custom Gibson short oligo ligation assembly enzymatic DNA synthesis solutions, which is designed to construct synthetic DNA, RNA, and proteins for development of mRNA-based vaccines, diagnostics, therapeutics, and personalized medicines. The company serves its products to government institutions, contract research organizations, and synthetic biology companies. The company was formerly known as Codex DNA, Inc. and changed its name to Telesis Bio Inc. in November 2022. Telesis Bio, Inc. was incorporated in 2011 and is headquartered in San Diego, California.

Telesis Bio Inc. Financial Data Overview

3.83
4.18
-
4.18
3.7601
3.025-24.48
6 790 K
1 773 K
19 566 K
-7.62
1.736
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'TBIO',
Type: 'Common Stock',
Name: 'Telesis Bio Inc.',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG011363VM3',
ISIN: NULL,
CUSIP: NULL,
CIK: '1850079',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2021-06-18',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Medical Devices',
HomeCategory: NULL,
IsDelisted: false,
}

Telesis Bio Inc. Fundamental Data is available in our Financial Data APIs

  • Net Revenue 19 566 K
  • EBITDA -32 888 000
  • Earnings Per Share -30.42
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Telesis Bio Inc. Earnings via APIs

  • Latest Release 2024-08-07
  • EPS/Forecast -4.03

Get Telesis Bio Inc. End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com